by Plus Therapeutics | Nov 15, 2024 | Uncategorized
ICYMI: Watch the Plus Therapeutics Q3 2024 Conference Call Webcast Replay Catch up on the latest financial results and updates from Plus Therapeutics! If you missed yesterday’s conference call, don’t worry – you can still access the webcast replay to hear...
by Plus Therapeutics | Nov 9, 2024 | Uncategorized
Join Plus Therapeutics at the Upcoming 5K Event in New York! Meet Our Patient Advocacy Team Speaking about ReSPECT-GBM and Recurrent Glioblastoma Don’t miss the chance to visit the Plus Therapeutics booth at the ABTA NYC community 5K next week in New York! We’re...
by Plus Therapeutics | Nov 8, 2024 | LM
You’re Invited: Symposium on Novel Targeted Radiotherapies for Leptomeningeal Metastases at the 2025 Society for Neuro-Oncology Annual Meeting in Houston Join Us at the SNO Annual Conference to Explore Groundbreaking Advances in Leptomeningeal Metastasis...
by Plus Therapeutics | Nov 6, 2024 | Uncategorized
BREAKING NEWS: Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy Press...
by Plus Therapeutics | Nov 4, 2024 | GBM
What a great glioblastoma patient summit hosted by @glioblastomaresearch🎗️🧠 We extend our heartfelt thanks to the organization for hosting this event, as well as to all the patients and caregivers who stopped by our booth and came to Dr. Brenner’s presentation...
Recent Comments